Sensydia is focused on developing technology for the rapid, non-invasive diagnosis and management of patients with heart disease. Their core product, the Sensydia Cardiac Performance System (CPS), is a portable, point-of-care hemodynamic measurement platform that utilizes proprietary sensor technology and machine learning. The CPS system aims to provide easy-to-use, non-invasive monitoring of key cardiac performance metrics to reduce readmissions, lower the cost of care, and improve outcomes for patients with heart disease. Sensydia's mission is to enable early disease detection and improve disease management through accurate and accessible hemodynamic insights, particularly in heart failure, sepsis, pulmonary hypertension, and other critical diseases.